Selection of Coxsackievirus B4 Variants with Monoclonal Antibodies Results in Attenuation

References

1. Cao Y., Schnurr D. P., Schmidt N. J. 1984a; Differing cardiotropic and myocarditic properties of group B type 4 Coxsackievirus strains. Archives of Virology 80:119–130
   [Google Scholar]
2. Cao Y., Schnurr D. p., Schmidt N. J. 1984b; Monoclonal antibodies for study of antigenic variation in coxsackievirus type B₄: association of antigenic determinants with myocarditic properties of the virus. Journal of General Virology 65:925–932
   [Google Scholar]
3. Coulon P., Rollin P., Aubert M., Flamand A. 1982; Molecular basis of rabies virus virulence. I. Selection of avirulent mutants of the CVS strain with anti-G monoclonal antibodies. Journal of General Virology 61:97–100
   [Google Scholar]
4. Dietzschold B., Wunner W. H., Wiktor T. I., Lopes A. D., Lafon M., Smith C. L., Koprowski H. 1983; Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proceedings of the National Academy of Sciences U.S.A.: 8070–74
   [Google Scholar]
5. Evans D. M. A., Dunn G., Minor P. D., Schild G. C., Cann A. J., Stanway G., Almond J. W., Currey K., Maizel J. V. Jr 1985; Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 polio vaccine genome. Nature; London: 314547–549
   [Google Scholar]
6. Fields B. N. 1983; How do viruses cause different diseases?. Journal of the American Medical Association 250:1754–1756
   [Google Scholar]
7. Gauntt C. J., Trousdale M. O., Labadie D. R. L., Paque R. E., Nealon T. 1979; Properties of Coxsackievirus B₃ variants which are amyocarditic or myocarditic for mice. Journal of Medical Virology 3:207–220
   [Google Scholar]
8. Hartig P. C., Webb S. R. 1983; Heterogeneity of a human isolate of Coxsackie B₄: biological differences. Journal of Infection 6:43–48
   [Google Scholar]
9. Hartig P. C., Madge G. E., Webb S. R. 1983; Diversity within a human isolate of Coxsackie B₄: relationship to virus induced diabetes. Journal of Medical Virology 11:23–30
   [Google Scholar]
10. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T₄ . Nature; London: 227680–685
    [Google Scholar]
11. Mccllntock P. R., Prabhakar B. S., Notkins A. L. 1986; Anti-idiotypic antibodies to monoclonal antibodies that neutralize Coxsackievirus B₄ do not recognize viral receptors. Virology 150:352–360
    [Google Scholar]
12. Prabhakar B. S., Notkins A. l. 1984; Antigenic variants of viruses and their relevance to clinical diseases. In Concepts in Viral Pathogenesis 1 pp 158–162 Notkins A. L., Oldstone M. B. A. Edited by New York: Springer-Verlag;
    [Google Scholar]
13. Prabhakar B. S., Haspel M. V., Mccllntock P. R., Notkins A. L. 1982; High frequency of antigenic variants among naturally-occurring human Coxsackie B₄ isolates identified by monoclonal antibodies. Nature; London: 300374–376
    [Google Scholar]
14. Prabhakar B. S., Mccllntock P. R., Haspel M. V., Wohlenberg C., Menegus M. A. 1983; Monoclonal antibodies as probes to study antigenic variations in Coxsackie B virus. Igiene moderna 80:1071–1079
    [Google Scholar]
15. Prabhakar B. S., Haspel M. V., Notkins A. L. 1984; Monoclonal antibody techniques applied to viruses. Methods in Virology 7:1–18
    [Google Scholar]
16. Prabhakar B. S., Menegus M. A., Notkins A. L. 1985; Detection of conserved and non-conserved epitopes on Coxsackievirus B₄: frequency of antigenic change. Virology 146:302–306
    [Google Scholar]
17. Reagan K. J., Goldberg B., Crowell R. 1984; Altered receptor specificity of Coxsackievirus B₃ after growth in rhabdomyosarcoma cells. Journal of Virology 49:635–640
    [Google Scholar]
18. Spriggs D. R., Bronson R, Fields B. N. 1983; Hemagglutinin variants of reovirus type 3 have altered central nervous system tropism. Science 220:505–507
    [Google Scholar]
19. Stec D. S., Waddel A., Schmaljohn C. S., Cole G. A., Schmaljohn A. L. 1986; Antibody selected variation and reversion in Sindbis virus neutralization epitopes. Journal of Virology 57:715–720
    [Google Scholar]
20. Webb S. R., Kearse K. P., Foulke C. L., Hartig P. C., Prabhakar B. S. 1986; Neutralization epitope diversity of Coxsackievirus B₄ isolates detected by monoclonal antibodies. Journal of Medical Virology 20:9–15
    [Google Scholar]
21. Yoon J. W., Mcclintock P. R., Onodera T., Notkins A. L. 1980; , Virus-induced diabetes mellitus. XVIII. Inhibition by a non-diabetogenic variant of encephalomyocarditis virus. Journal of Experimental Medicine 152:878–892
    [Google Scholar]